Astro Health's AI-Powered Dementia Care-Support Platform Accepted for Presentation at AAIC 2026

SAN FRANCISCO - April 2, 2026 - PRLog -- San Francisco, CA— Astro Health Inc. today announced that its groundbreaking research abstract, "A Novel Artificial Intelligence Powered Precision Care-Support Platform for Improving Functionality, Extending Independence and Reducing Falls in People Living with Mild Cognitive Impairment (MCI) and Dementia," has been accepted for presentation at the Alzheimer's Association International Conference (AAIC) 2026 — the world's leading scientific meeting dedicated to Alzheimer's disease and dementia research.

This system introduces a first-of-its-kind artificial intelligence (AI)-powered digital health platform designed to support individuals living with Mild Cognitive Impairment (MCI) and dementia through a comprehensive, "whole-person" reablement approach.

Addressing a Critical Global Need
As highlighted in the 2025 World Alzheimer Report, dementia care requires integrated solutions that address not only cognitive decline but also physical, social, and environmental factors impacting daily functioning. Loss of independence and confidence significantly contributes to disease burden for both patients and caregivers. Astro Health's platform directly responds to this need by delivering an intelligent, personalized care-support system aimed at improving quality of life while reducing risks such as falls.

Innovative AI-Driven Approach

The platform leverages advanced neural network models to assess multiple dimensions of health, including:

• Speech and language patterns
• Mobility and gait analysis
• Neuropsychological and functional biomarkers
• Mental health and cognitive processing

A key feature of the system is its human-in-the-loop model, where trained health advocates interpret AI-generated insights to design personalized reablement plans tailored to each individual's goals and daily living needs.

Additionally, the platform integrates environmental sensors for real-time fall detection in care settings, enabling proactive interventions and enhanced patient safety.

Real-World Clinical Validation

A clinical validation study is planned in collaboration with Los Angeles General Medical Center, involving participants living with dementia. The study represents the first real-world patient validation effort of an AI-powered reablement platform for individuals with MCI and dementia.

The AAIC presentation will highlight:

• The system's architecture and design framework
• Progress in AI model development for early MCI assessment and dementia detection
• Integration of speech and mobility-based biomarkers

Transforming Dementia Care

This innovative platform has the potential to:

• Improve functional independence and daily living outcomes
• Enhance quality of life for patients
• Reduce caregiver burden
• Deliver meaningful healthcare cost savings by alleviating pressure on clinical staff and long-term care systems

About Astro Health Inc. Astro Health Inc. is a digital health company focused on developing AI-driven solutions to improve care delivery, patient outcomes, and quality of life for individuals living with complex and chronic conditions.

Media Contact:
Shraddha Chaugule, PhD
CEO, Astro Health Inc
shrads@astrohealth.ai +1 619 999 7391
For more information, visit: https://astrohealth.ai/